Concurrent Session 3A: Strategy, measurement and elimination targets
Tracks
Track 1
| Thursday, August 13, 2026 |
| 2:15 PM - 3:15 PM |
Speaker
Ashma Shrestha
Lead Policy Analyst
Hepatitis Australia
Modelling the Health and Economic Impacts of Falling Short of the 2030 Hepatitis B and Hepatitis C Elimination Targets
2:20 PM - 2:32 PMBiography
Ashma Shrestha is the Lead Policy Analyst at Hepatitis Australia. She brings extensive experience in policy advocacy, strategic communications, and social and behaviour change programming across global health and within Australia. Before joining Hepatitis Australia, Ashma worked with UN Women and UNICEF in South Asia, the Middle East, and Africa
Mr Jason Asselin
Head Of Surveillance & Data Linkage
Burnet Institute
Estimating changes in HCV RNA positivity after broad access to HCV treatment using routinely collected clinical data from a national clinical surveillance network
2:35 PM - 2:47 PMBiography
Jason joined the Burnet Institute after eight years in HIV community prevention. As Head of Surveillance & Data Linkage, he oversees the ACCESS national sentinel surveillance system of clinical services and laboratories, monitoring blood‐borne viruses and sexually transmissible infections.
Cecile Castellano
Senior Policy Officer
NSW Ministry of Health
The evolving hepatitis C landscape – findings from stakeholder consultations for the 2026-28 New South Wales Hepatitis C Strategy
2:50 PM - 3:02 PMBiography
Cecile is a Senior Policy Officer in the Hepatitis Policy and Programs Unit at the NSW Ministry of Health, supporting implementation of the NSW Hepatitis B and Hepatitis C Strategies. She has experience in public health policy, clinical research, and management consulting and is passionate about equitable healthcare.
Cecile Castellano
Senior Policy Officer
NSW Ministry of Health
Developing the NSW Aboriginal Blood-borne Viruses and Sexually Transmissible Infections Framework
3:05 PM - 3:08 PMBiography
Cecile is a Senior Policy Officer in the Hepatitis Policy and Programs Unit at the NSW Ministry of Health, supporting implementation of the NSW Hepatitis B and Hepatitis C Strategies. She has experience in public health policy, clinical research, and management consulting and is passionate about equitable healthcare.
Ashma Shrestha
Lead Policy Analyst
Hepatitis Australia
Developing a Hepatitis B National Monitoring and Care Facilitation Program in Australia
3:10 PM - 3:15 PMBiography
Ashma Shrestha is the Lead Policy Analyst at Hepatitis Australia. She brings extensive experience in policy advocacy, strategic communications, and social and behaviour change programming across global health and within Australia. Before joining Hepatitis Australia, Ashma worked with UN Women and UNICEF in South Asia, the Middle East, and Africa
